UCB says had positive trial for Vimpat as monotherapy
BRUSSELS (Reuters) - Belgian pharmaceutical company UCB said on Tuesday its new epilepsy treatment Vimpat had produced promising results in a Phase II...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/04LAcutIINk/us-ucb-vimpat-idUSBRE92407U20130305
No comments:
Post a Comment